title: Intraplantar injection of nerve growth factor into the rat hind paw: local edema and effects on thermal nociceptive threshold.
abstract: Nerve growth factor (NGF) is known to produce hyperalgesia as well as to stimulate synthesis of neuropeptides in dorsal root ganglia (DRG). In the present study, we wanted to determine the effects of local NGF administration and assess to which extent mast cell-dependent factors are mediating NGF responses. Rats received 1 daily unilateral intraplantar injection for 3 days. Local edema (days 1-3), changes in thermal nociceptive threshold (days 1-4), and the content of calcitonin gene-related peptide (CGRP) and substance P (SP) in the sciatic nerve (day 4), were determined. NGF injection caused edema which was absent in rats pretreated with compound 48/80 as well as in rats treated neonatally with capsaicin ('capsaicin denervation'). NGF-induced edema was not reduced by the neurokinin-1 receptor antagonist SR140333, but attenuated by the CGRP receptor antagonist CGRP[8-37]. On each day, NGF injection caused a decrease in thermal nociceptive threshold which lasted for less than 3 h. Capsaicin denervation, but not treatment with indomethacin, abolished NGF-induced thermal hyperalgesia. Treatment with compound 48/80 attenuated hyperalgesia produced by the first, but not by subsequent, NGF injections. On day 4, 24 h after the last of 3 NGF injections, thermal nociceptive threshold was not different from control values, but at that time, CGRP and SP were elevated in the sciatic nerve. We suggest therefore that NGF-induced local edema was caused by mast cell-derived vasoactive compounds which act together with afferent neuron-derived CGRP to increase vascular permeability. NGF-induced thermal hyperalgesia most likely was caused by an increased sensitivity of peripheral endings of capsaicin sensitive afferents. This effect of NGF was not mediated by products of the cyclooxygenase pathway, and was also observed in mast cell-depleted rats.
authors: Department of Experimental and Clinical Pharmacology, Graz University, A-8010 Graz Austria.
authors: Rainer
authors: R
authors: Amann
authors: Rufina
authors: R
authors: Schuligoi
authors: Gernot
authors: G
authors: Herzeg
authors: Josef
authors: J
authors: Donnerer
mesh_terms: D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism; D002211:Capsaicin / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D003714:Denervation; D004487:Edema / Q000139:chemically induced* / Q000473:pathology / Q000523:psychology; D005528:Foot / Q000473:pathology; D006632:Histamine / Q000378:metabolism; D007267:Injections; D008297:Male; D008407:Mast Cells / Q000187:drug effects; D009414:Nerve Growth Factors / Q000008:administration & dosage / Q000633:toxicity*; D009475:Neurons, Afferent / Q000187:drug effects; D017288:Pain Threshold / Q000187:drug effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012584:Sciatic Nerve / Q000187:drug effects / Q000378:metabolism; D013373:Substance P / Q000378:metabolism
chemical_list: D016861:Cyclooxygenase Inhibitors; D009414:Nerve Growth Factors; D013373:Substance P; D006632:Histamine; D015740:Calcitonin Gene-Related Peptide; D002211:Capsaicin